Chemical Compound

NADH

CAS Registry Number 58-68-4

Back to search Request a Quote

Primary Record

NADH

In stock: 2,569 g
Purity: 98.4 %
CAS: 58-68-4

Compound Identifiers & Properties

CAS: 58-68-4
PubChem CID: 439153
SMILES: C1C=CN(C=C1C(=O)N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O
Canonical SMILES: NC(=O)C1=CN([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)C=CC1

Names & Synonyms

NADH
beta-NADH
DPNH
Dihydrocozymase
beta-DPNH
Coenzyme I, reduced
Cozymase I, reduced
NADH2
nadide
NAD-reduced
Dihydrocodehydrogenase I
nadh hydride
NAD reduced form
coenzyme-I
b-dpnh
Reduced codehydrogenase I
NAD reduced
Dihydrocoenzyme I
NADH dianion
Codehydrase I, reduced
Reduced Co I
Reduced coenzyme I
1,4-Dihydronicotinamide adenine dinucleotide
ENADA
Codehydrogenase I, reduced
Reduced codehydrase I
b-NADH
dihydronicotinamide adenine dinucleotide
Dihydronicotinamide mononucleotide
NADH+H+
58-68-4
Reduced nicotinamide adenine diphosphate
DPN+
NAD+
Reduced diphosphopyridine nucleotide
beta-NADH Disodium Salt
RefChem:552993
Reduced nicotinamide-adenine dinucleotide
NADH [WHO-DD]
diphosphopyridine nucleotide
bmse000054
D0B8SV
AC1L96RW
SCHEMBL8187
SCHEMBL8188
UNII-4J24DQ0916
CHEBI:16908
Dihydronicotinamide-adenine dinucleotide
dihydrodiphosphopyridine nucleotide
DTXSID30889320
Nicotinaminde-Adenine-Dinucleotide
BOPGDPNILDQYTO-NNYOXOHSSA-N
NAD REDUCED FORM [MI]
GTPL4487
orb2563829
diphosphopyridine nucleotide reduced
nicotinamide adenine dinucleotide
Reduced Nicotinamide Adenine Dinucleotide
4J24DQ0916
CHEMBL1234616
SCHEMBL29350404
UNII-8295030YNC
EINECS 200-393-0
Nicotinamide-Adenine-Dinucleotide
C21H29N7O14P2.2Na
DTXCID301028583
C21H29N7O14P2
Nicotinamide-adenine dinucleotide, reduced
nicotinamide adenine dinucleotide (reduced)
ZINC8215403
EINECS 210-123-3
nicotinamide adenine dinucleotide reduced
CID439153
CN-089
EBC-27420
ACN-037790
DB00157
Dihydronicotinamide formycin dinucleotide
Diphosphopyridine nucleotide,reduced form
Nicotinamide - adenine dinucleotide, reduced
Adenine Dinucleotide, Dihydronicotinamide
C21-H29-N7-O14-P2
C21-H29-N7-O14-P2.2Na
HY-113355
J213.546I
beta-Nicotinamid adenine dinucleotide reduced
CS-0062281
606-68-8
6453-EP1441224A2
6453-EP2269610A2
6453-EP2272834A1
6453-EP2275414A1
6453-EP2277876A1
6453-EP2277898A2
6453-EP2284149A1
6453-EP2289510A1
6453-EP2292614A1
6453-EP2292630A1
6453-EP2295417A1
6453-EP2295435A1
6453-EP2298312A1
6453-EP2298743A1
6453-EP2301929A1
6453-EP2301935A1
6453-EP2305674A1
6453-EP2308960A1
6453-EP2316457A1
6453-EP2316458A1
6453-EP2316825A1
6453-EP2316826A1
6453-EP2316827A1
6453-EP2316828A1
6453-EP2374895A1
C00004
Dihydronicotinamide-adenine dinucleotide (NADH)
Nicotinamide adenine dinucleotide, reduced form
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate
EN300-19742425
1,4,5,6-Tetrahydronicotinamide adenine dinucleotide
BRD-A84188517-304-01-1
Dihydronicotinamide-adenine dinucleotide, disodium salt
NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM)
Q26987453
REDUCED BETA-NICOTINAMIDE ADENINE DINUCLEOTIDE
Nicotinamide-adenine dinucleotide, reduced, disodium salt
Nicotinamid-adenin-dinucleotid(reduced)disodiumsaltgradei(nad
Reduced beta-nicotinamide adenine dinucleotide disodium salt
Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide
Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with 1,4-dihydro-1beta-D-ribofuranosylnicotinamide
beta-Nicotinamide adenine dinucleotide, reduced dipotassium salt
((2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy-((((2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy)hydroxyphosphoryl)oxyphosphinic acid
[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinic acid
[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-[[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-phosphinic acid
Adenosine 5'-(trihydrogen diphosphate), P'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide
Adenosine 5'-(trihydrogen diphosphate), P'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide (9CI)
Adenosine 5'-(trihydrogen pyrophosphate), 5'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosylnicotinamide (8CI)
adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate}
Adenosine pyrophosphate, 5'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosylnicotinamide (7CI)
NAD
1-[5-O-(5 -Adenylyloxyphosphonyl)-beta-D-ribofuranosyl]-1,4-dihydronicotinamide
beta-Nicotinamide adenine dinucleotide, reduced form, (Reduced Coenzyme-I) disodium salt
(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)(hydroxy)phosphoryl)oxy)((((2R,3S,4R,5R)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl)methoxy))phosphinic acid
(((2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy-hydroxyphosphoryl) ((2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl)methyl hydrogen phosphate
((2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)methyl (((2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl)methoxy-hydroxyphosphoryl) hydrogen phosphate
[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1(4H)-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen diphosphate
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate
[[(2~{r},3~{s},4~{r},5~{r})-5-(5-Aminocarbonyl-2~{h}-Pyridin-1-Yl)-3,4-Bis(Oxidanyl)oxolan-2-Yl]methoxy-Oxidanyl-Phosphoryl] [(2~{r},3~{s},4~{r},5~{r})-5-(6-Aminopurin-9-Yl)-3,4-Bis(Oxidanyl)oxolan-2-Yl]methyl Hydrogen Phosphate
[5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [[5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate
200-393-0
6V0
Adenosine 5 -[diphosphoric acid beta-[1-(3-carbamoyl-1,4-dihydropyridine-1-yl)-1,5-dideoxy-beta-D-ribofuranose-5-yl]] ester
Adenosine 5 -[diphosphoric acid P2-[1-(1,4-dihydro-3-carbamoylpyridin-1-yl)-1,5-dideoxy-beta-D-ribo-pentofuranos-5-yl]] ester
Adenosine 5'-(trihydrogen diphosphate), 5'->'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide
Adenosine 5'-(trihydrogen diphosphate), 5'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide
Adenosine 5'-(trihydrogen diphosphate), 5'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide, disodium salt
ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE), P'->5'-ESTER WITH 1,4-DIHYDRO-1-.BETA.-D-RIBOFURANOSYL-3-PYRIDINECARBOXAMIDE
Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide, disodium salt
Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide
Adenosine 5'-(trihydrogen diphosphate), P'?5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide, disodium salt
Adenosine 5'-(trihydrogen diphosphate), P'a5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide
adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate}
DPN
NAI
NAJ
TXD